VERTEX PHARMACEUTICALS INC / MA Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised of $74.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2026-06-30 was $47.70M, a 2.85% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2026-03-31 was $27.00M, a 61.68% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2025-12-31 was $54.00M, a 57.43% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2025-09-30 was $7.90M, a 5.95% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2025 was $127.70M, a 11.43% increase from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2024 was $114.60M, a 14.86% decline from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2023 was $134.60M, a 27.75% decline from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2022 was $186.30M, a 82.65% increase from fiscal 2021.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 3 month as first filed | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 6 month as first filed | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 9 month as first filed | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 12 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $47.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $74.70M 10-Q · filed 2026-08-04 | $128.70M derived: sum of 3 quarters · filed 2026-08-04 | $136.60M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $27.00M 10-Q · filed 2026-05-05 | $81.00M derived: sum of 2 quarters · filed 2026-05-05 | $88.90M derived: sum of 3 quarters · filed 2026-05-05 | $138.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $54.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $61.90M derived: sum of 2 quarters · filed 2026-02-13 | $111.00M derived: sum of 3 quarters · filed 2026-08-04 | $127.70M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $7.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $57.00M derived: sum of 2 quarters · filed 2026-08-04 | $73.70M 10-Q · filed 2025-11-04 | $108.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $49.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $65.80M 10-Q · filed 2026-08-04 | $100.10M derived: sum of 3 quarters · filed 2026-08-04 | $108.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $16.70M 10-Q · filed 2026-05-05 | $51.00M derived: sum of 2 quarters · filed 2026-05-05 | $59.40M derived: sum of 3 quarters · filed 2026-05-05 | $114.40M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $34.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $42.70M derived: sum of 2 quarters · filed 2026-02-13 | $97.70M derived: sum of 3 quarters · filed 2026-02-13 | $114.60M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $63.40M derived: sum of 2 quarters · filed 2025-11-04 | $80.30M 10-Q · filed 2025-11-04 | $126.70M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $55.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $71.90M 10-Q · filed 2025-08-05 | $118.30M derived: sum of 3 quarters · filed 2026-02-13 | $133.70M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $16.90M 10-Q · filed 2025-05-06 | $63.30M derived: sum of 2 quarters · filed 2026-02-13 | $78.70M derived: sum of 3 quarters · filed 2026-02-13 | $137.30M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $46.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $61.80M derived: sum of 2 quarters · filed 2026-02-13 | $120.40M derived: sum of 3 quarters · filed 2026-02-13 | $134.60M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $15.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $74.00M derived: sum of 2 quarters · filed 2024-11-05 | $88.20M 10-Q · filed 2024-11-05 | $139.80M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $58.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $72.80M 10-Q · filed 2024-08-02 | $124.40M derived: sum of 3 quarters · filed 2025-02-13 | $161.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $14.20M 10-Q · filed 2024-05-07 | $65.80M derived: sum of 2 quarters · filed 2025-02-13 | $102.40M derived: sum of 3 quarters · filed 2025-02-13 | $166.80M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $51.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $88.20M derived: sum of 2 quarters · filed 2025-02-13 | $152.60M derived: sum of 3 quarters · filed 2025-02-13 | $186.30M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $36.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $101.00M derived: sum of 2 quarters · filed 2023-11-07 | $134.70M 10-Q · filed 2023-11-07 | $169.40M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $64.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $98.10M 10-Q · filed 2023-08-02 | $132.80M derived: sum of 3 quarters · filed 2024-02-15 | $146.60M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $33.70M 10-Q · filed 2023-05-02 | $68.40M derived: sum of 2 quarters · filed 2024-02-15 | $82.20M derived: sum of 3 quarters · filed 2024-02-15 | $120.10M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $34.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $48.50M derived: sum of 2 quarters · filed 2024-02-15 | $86.40M derived: sum of 3 quarters · filed 2024-02-15 | $102.00M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $13.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $51.70M derived: sum of 2 quarters · filed 2022-10-28 | $67.30M 10-Q · filed 2022-10-28 | $67.29M 10-Q · filed 2021-11-03 | $97.35M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-06-30 | $37.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $53.50M 10-Q · filed 2022-08-05 | $53.49M 10-Q · filed 2021-07-30 | $83.55M derived: sum of 3 quarters · filed 2023-02-10 | $105.34M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-03-31 | $15.60M 10-Q · filed 2022-05-06 | $15.56M 10-Q · filed 2021-04-30 | $45.65M derived: sum of 2 quarters · filed 2023-02-10 | $67.44M derived: sum of 3 quarters · filed 2023-02-10 | $200.90M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $30.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $51.84M derived: sum of 2 quarters · filed 2023-02-10 | $185.30M derived: sum of 3 quarters · filed 2023-02-10 | $264.90M 10-K · filed 2023-02-10 | $264.95M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $21.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $155.26M derived: sum of 2 quarters · filed 2021-11-03 | $234.85M 10-Q · filed 2021-11-03 | $433.42M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $133.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $213.06M 10-Q · filed 2021-07-30 | $411.63M derived: sum of 3 quarters · filed 2022-02-09 | $442.17M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $79.60M 10-Q · filed 2021-04-30 | $278.17M derived: sum of 2 quarters · filed 2022-02-09 | $308.70M derived: sum of 3 quarters · filed 2022-02-09 | $359.18M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $198.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $229.11M derived: sum of 2 quarters · filed 2022-02-09 | $279.58M derived: sum of 3 quarters · filed 2022-02-09 | $343.20M 10-K · filed 2022-02-09 | $343.24M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $30.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $81.01M derived: sum of 2 quarters · filed 2020-10-30 | $144.63M 10-Q · filed 2020-10-30 | $188.17M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $50.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $114.09M 10-Q · filed 2020-07-31 | $157.63M derived: sum of 3 quarters · filed 2021-02-11 | $258.55M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $63.62M 10-Q · filed 2020-05-01 | $107.16M derived: sum of 2 quarters · filed 2021-02-11 | $208.08M derived: sum of 3 quarters · filed 2021-02-11 | $264.51M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $43.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $144.46M derived: sum of 2 quarters · filed 2021-02-11 | $200.89M derived: sum of 3 quarters · filed 2021-02-11 | $289.29M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $100.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $157.35M derived: sum of 2 quarters · filed 2019-10-31 | $245.75M 10-Q · filed 2019-10-31 | $292.39M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $56.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $144.84M 10-Q · filed 2019-08-01 | $191.47M derived: sum of 3 quarters · filed 2020-02-13 | $341.79M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $88.40M 10-Q · filed 2019-05-01 | $135.04M derived: sum of 2 quarters · filed 2020-02-13 | $285.36M derived: sum of 3 quarters · filed 2020-02-13 | $421.99M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $46.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $196.95M derived: sum of 2 quarters · filed 2020-02-13 | $333.59M derived: sum of 3 quarters · filed 2020-02-13 | $344.84M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $150.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $286.96M derived: sum of 2 quarters · filed 2018-10-25 | $298.20M 10-Q · filed 2018-10-25 | $315.27M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $136.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $147.89M 10-Q · filed 2018-07-26 | $164.95M derived: sum of 3 quarters · filed 2019-02-13 | $182.41M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $11.25M 10-Q · filed 2018-04-27 | $28.31M derived: sum of 2 quarters · filed 2019-02-13 | $45.78M derived: sum of 3 quarters · filed 2019-02-13 | $70.63M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $17.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $34.53M derived: sum of 2 quarters · filed 2019-02-13 | $59.38M derived: sum of 3 quarters · filed 2019-02-13 | $68.23M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $17.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $42.32M derived: sum of 2 quarters · filed 2017-10-30 | $51.16M 10-Q · filed 2017-10-30 | $97.07M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $24.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $33.70M 10-Q · filed 2017-07-28 | $79.61M derived: sum of 3 quarters · filed 2018-02-15 | $131.44M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $8.85M 10-Q · filed 2017-04-28 | $54.75M derived: sum of 2 quarters · filed 2018-02-15 | $106.59M derived: sum of 3 quarters · filed 2018-02-15 | $152.82M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $45.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $97.74M derived: sum of 2 quarters · filed 2018-02-15 | $143.98M derived: sum of 3 quarters · filed 2018-02-15 | $185.59M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $51.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $98.07M derived: sum of 2 quarters · filed 2016-10-31 | $139.69M 10-Q · filed 2016-10-31 | $213.03M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $46.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $87.85M 10-Q · filed 2016-08-01 | $161.19M derived: sum of 3 quarters · filed 2017-02-23 | $244.52M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $41.62M 10-Q · filed 2016-05-03 | $114.96M derived: sum of 2 quarters · filed 2017-02-23 | $198.28M derived: sum of 3 quarters · filed 2017-02-23 | $256.10M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $73.34M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $156.67M derived: sum of 2 quarters · filed 2017-02-23 | $214.48M derived: sum of 3 quarters · filed 2017-02-23 | $274.62M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $83.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $141.14M derived: sum of 2 quarters · filed 2015-10-30 | $201.27M 10-Q · filed 2015-10-30 | $224.79M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | $57.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $117.95M 10-Q · filed 2015-08-04 | $141.47M derived: sum of 3 quarters · filed 2016-02-16 | $175.95M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $60.13M 10-Q · filed 2015-05-04 | $83.65M derived: sum of 2 quarters · filed 2016-02-16 | $118.14M derived: sum of 3 quarters · filed 2016-02-16 | $304.34M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | $23.52M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $58.01M derived: sum of 2 quarters · filed 2016-02-16 | $244.21M derived: sum of 3 quarters · filed 2016-02-16 | $265.88M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | $34.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $220.69M derived: sum of 2 quarters · filed 2014-11-06 | $242.36M 10-Q · filed 2014-11-06 | $259.13M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | $186.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $207.87M 10-Q · filed 2014-07-31 | $224.64M derived: sum of 3 quarters · filed 2015-02-13 | $241.59M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $21.67M 10-Q · filed 2014-05-05 | $38.44M derived: sum of 2 quarters · filed 2015-02-13 | $55.39M derived: sum of 3 quarters · filed 2015-02-13 | $192.09M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $16.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $33.72M derived: sum of 2 quarters · filed 2015-02-13 | $170.42M derived: sum of 3 quarters · filed 2015-02-13 | $191.72M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $16.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $153.65M derived: sum of 2 quarters · filed 2013-11-07 | $174.95M 10-Q · filed 2013-11-07 | $191.07M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | $136.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $158.00M 10-Q · filed 2013-08-02 | $174.12M derived: sum of 3 quarters · filed 2014-02-11 | $194.19M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | $21.30M 10-Q · filed 2013-05-08 | $37.42M derived: sum of 2 quarters · filed 2014-02-11 | $57.49M derived: sum of 3 quarters · filed 2014-02-11 | $112.52M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $16.12M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $36.19M derived: sum of 2 quarters · filed 2014-02-11 | $91.22M derived: sum of 3 quarters · filed 2014-02-11 | $124.86M 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | $20.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $75.10M derived: sum of 2 quarters · filed 2012-11-06 | $108.74M 10-Q · filed 2012-11-06 | $118.19M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $55.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $88.67M 10-Q · filed 2012-08-08 | $98.12M derived: sum of 3 quarters · filed 2013-03-01 | $104.97M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $33.64M 10-Q · filed 2012-05-10 | $43.09M derived: sum of 2 quarters · filed 2013-03-01 | $49.94M derived: sum of 3 quarters · filed 2013-03-01 | $59.41M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $9.45M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $16.30M derived: sum of 2 quarters · filed 2013-03-01 | $25.77M derived: sum of 3 quarters · filed 2013-03-01 | $33.43M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $6.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $16.32M derived: sum of 2 quarters · filed 2011-11-03 | $23.99M 10-Q · filed 2011-11-03 | $46.88M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $9.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $17.14M 10-Q · filed 2011-08-09 | $40.03M derived: sum of 3 quarters · filed 2012-02-22 | $48.40M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $7.66M 10-Q · filed 2011-05-06 | $30.55M derived: sum of 2 quarters · filed 2012-02-22 | $38.93M derived: sum of 3 quarters · filed 2012-02-22 | $50.10M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $22.89M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $31.27M derived: sum of 2 quarters · filed 2012-02-22 | $42.43M derived: sum of 3 quarters · filed 2012-02-22 | $47.85M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $8.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $19.54M derived: sum of 2 quarters · filed 2010-10-28 | $24.96M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $11.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | $16.58M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | $5.42M 10-Q · filed 2010-05-03 | |||||||
| 2008-12-31 | $31.98M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |